Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justus Nonhoff

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Heart Journal|February 1, 2015
Peripartum cardiomyopathy: current management and future perspectivesDenise Hilfiker-Kleiner, Arash Haghikia, Justus Nonhoff, et al.
Cardiovascular Research|April 29, 2017
Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathyJustus Nonhoff, Melanie Ricke-Hoch, Mirco Mueller, et al.
European Journal of Heart Failure|March 28, 2017
Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathyDenise Hilfiker-Kleiner, Arash Haghikia, David Masuko, et al.
Cardiovascular Research|November 12, 2019
In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial rolesMelanie Ricke-Hoch, Martijn F Hoes, Tobias J Pfeffer, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Heart Journal|February 1, 2015
Peripartum cardiomyopathy: current management and future perspectivesDenise Hilfiker-Kleiner, Arash Haghikia, Justus Nonhoff, et al.
Cardiovascular Research|April 29, 2017
Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathyJustus Nonhoff, Melanie Ricke-Hoch, Mirco Mueller, et al.
European Journal of Heart Failure|March 28, 2017
Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathyDenise Hilfiker-Kleiner, Arash Haghikia, David Masuko, et al.
Cardiovascular Research|November 12, 2019
In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial rolesMelanie Ricke-Hoch, Martijn F Hoes, Tobias J Pfeffer, et al.
Pageof 1